MX2012001018A - Anticuerpo marcador de celula beta. - Google Patents
Anticuerpo marcador de celula beta.Info
- Publication number
- MX2012001018A MX2012001018A MX2012001018A MX2012001018A MX2012001018A MX 2012001018 A MX2012001018 A MX 2012001018A MX 2012001018 A MX2012001018 A MX 2012001018A MX 2012001018 A MX2012001018 A MX 2012001018A MX 2012001018 A MX2012001018 A MX 2012001018A
- Authority
- MX
- Mexico
- Prior art keywords
- cell marker
- beta cell
- marker antibody
- antibody directed
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Abstract
La presente invención se refiere a un anticuerpo dirigido a una proteína marcadora de célula beta, en particular a un anticuerpo dirigido a la proteína TMEM27.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09167160 | 2009-08-04 | ||
PCT/EP2010/061078 WO2011015521A1 (en) | 2009-08-04 | 2010-07-30 | Beta cell marker antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012001018A true MX2012001018A (es) | 2012-02-21 |
Family
ID=42938156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012001018A MX2012001018A (es) | 2009-08-04 | 2010-07-30 | Anticuerpo marcador de celula beta. |
Country Status (13)
Country | Link |
---|---|
US (1) | US8512704B2 (es) |
EP (1) | EP2462163A1 (es) |
JP (1) | JP5684259B2 (es) |
KR (1) | KR20120051733A (es) |
CN (1) | CN102471383B (es) |
AU (1) | AU2010280847B2 (es) |
BR (1) | BR112012002460A2 (es) |
CA (1) | CA2768745C (es) |
HK (1) | HK1170503A1 (es) |
IL (1) | IL217371A0 (es) |
MX (1) | MX2012001018A (es) |
SG (1) | SG178210A1 (es) |
WO (1) | WO2011015521A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012113718A1 (en) * | 2011-02-21 | 2012-08-30 | Roche Diagnostics Gmbh | A diagnostic method for type ii diabetes |
EP2888576B1 (en) | 2012-08-21 | 2023-10-04 | Akoya Biosciences, Inc. | Visualization and measurement of cell compartments |
WO2017182605A1 (en) * | 2016-04-22 | 2017-10-26 | Université Libre de Bruxelles | A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells |
US11597744B2 (en) | 2017-06-30 | 2023-03-07 | Sirius Therapeutics, Inc. | Chiral phosphoramidite auxiliaries and methods of their use |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5204244A (en) | 1987-10-27 | 1993-04-20 | Oncogen | Production of chimeric antibodies by homologous recombination |
US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
US7018809B1 (en) | 1991-09-19 | 2006-03-28 | Genentech, Inc. | Expression of functional antibody fragments |
US5397703A (en) * | 1992-07-09 | 1995-03-14 | Cetus Oncology Corporation | Method for generation of antibodies to cell surface molecules |
US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
NZ545968A (en) * | 2003-09-18 | 2010-01-29 | Raven Biotechnologies Inc | KID3 and KID3 antibodies that bind thereto |
CA2611002A1 (en) * | 2005-06-07 | 2006-12-14 | The Rockefeller University | Stimulation of pancreatic .beta. cell proliferation |
US8124738B2 (en) * | 2005-09-26 | 2012-02-28 | Medarex, Inc. | Human monoclonal antibodies to CD70 |
-
2010
- 2010-07-30 EP EP10735300A patent/EP2462163A1/en not_active Withdrawn
- 2010-07-30 KR KR1020127005687A patent/KR20120051733A/ko not_active Application Discontinuation
- 2010-07-30 CN CN201080034289.9A patent/CN102471383B/zh not_active Expired - Fee Related
- 2010-07-30 MX MX2012001018A patent/MX2012001018A/es active IP Right Grant
- 2010-07-30 JP JP2012523296A patent/JP5684259B2/ja not_active Expired - Fee Related
- 2010-07-30 CA CA2768745A patent/CA2768745C/en not_active Expired - Fee Related
- 2010-07-30 AU AU2010280847A patent/AU2010280847B2/en not_active Ceased
- 2010-07-30 SG SG2012007100A patent/SG178210A1/en unknown
- 2010-07-30 BR BR112012002460A patent/BR112012002460A2/pt not_active IP Right Cessation
- 2010-07-30 US US13/388,974 patent/US8512704B2/en not_active Expired - Fee Related
- 2010-07-30 WO PCT/EP2010/061078 patent/WO2011015521A1/en active Application Filing
-
2012
- 2012-01-04 IL IL217371A patent/IL217371A0/en unknown
- 2012-11-07 HK HK12111220.5A patent/HK1170503A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2768745C (en) | 2015-02-03 |
EP2462163A1 (en) | 2012-06-13 |
AU2010280847A1 (en) | 2012-02-09 |
SG178210A1 (en) | 2012-03-29 |
CN102471383A (zh) | 2012-05-23 |
IL217371A0 (en) | 2012-02-29 |
HK1170503A1 (en) | 2013-03-01 |
CA2768745A1 (en) | 2011-02-10 |
JP5684259B2 (ja) | 2015-03-11 |
AU2010280847B2 (en) | 2012-12-13 |
US20120134927A1 (en) | 2012-05-31 |
JP2013501023A (ja) | 2013-01-10 |
BR112012002460A2 (pt) | 2016-11-08 |
CN102471383B (zh) | 2014-09-17 |
WO2011015521A1 (en) | 2011-02-10 |
US8512704B2 (en) | 2013-08-20 |
KR20120051733A (ko) | 2012-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011011925A (es) | Anticuerpos triespecificos o tetraespecificos. | |
WO2010088633A3 (en) | Novel cell lines and methods | |
BR112012000107A2 (pt) | receptores de células t. | |
BRPI1009416A2 (pt) | célula solar. | |
BR112012002226A2 (pt) | anticorpos muc1. | |
CL2009001263S1 (es) | Maquina de afeitar. | |
AP2011005719A0 (en) | Anti-IGF antibodies. | |
EA201290638A1 (ru) | Соединения и способы | |
AP2010005424A0 (en) | Assays. | |
ZA201206842B (en) | A novel ethanologenic clostridium species, clostridium coskatii | |
BR112012000281A2 (pt) | proteína quimérica. | |
DE112009005162T8 (de) | Brennstoffzellensystem | |
BRPI0822950A2 (pt) | Estação de carga. | |
EP2516624A4 (en) | CELL LINE 3M | |
AP2011005984A0 (en) | Antibodies specific to cadherin-17. | |
BR112012013418A2 (pt) | marcador sérico bioquímico. | |
CO6241120A2 (es) | (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS. | |
DE112009005341T8 (de) | Brennstoffzellensystem | |
IN2012DN02073A (es) | ||
BRPI1012093A2 (pt) | válvula, especialmente válvula de cola | |
WO2009102569A3 (en) | Cell lines and methods for making and using them | |
DE112009005443B8 (de) | Brennstoffzellensystem | |
MX2012001018A (es) | Anticuerpo marcador de celula beta. | |
AP2012006120A0 (en) | Fuel cell. | |
AP2012006259A0 (en) | Fuel cell system. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |